{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T19:14:38Z","timestamp":1648926878319},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T00:00:00Z","timestamp":1540771200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00105-018-4291-6","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T09:12:05Z","timestamp":1540804325000},"page":"183-188","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["85\/m mit Blasen am gesamten Integument"],"prefix":"10.1007","volume":"69","author":[{"given":"Mareike","family":"Witte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enno","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,29]]},"reference":[{"key":"4291_CR1","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","volume":"381","author":"E Schmidt","year":"2013","unstructured":"Schmidt E, Zillikens D (2013) Pemphigoid diseases. Lancet 381:320\u2013332. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(12)61140-4","journal-title":"Lancet"},{"key":"4291_CR2","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1016\/j.jid.2016.07.013","volume":"136","author":"F H\u00fcbner","year":"2016","unstructured":"H\u00fcbner F, Recke A, Zillikens D et\u00a0al (2016) Prevalence and age distribution of pemphigus and pemphigoid diseases in Germany. J\u00a0Invest Dermatol 136:2495\u20132498. \n                    https:\/\/doi.org\/10.1016\/j.jid.2016.07.013","journal-title":"J Invest Dermatol"},{"key":"4291_CR3","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/exd.13446","volume":"26","author":"S Goletz","year":"2017","unstructured":"Goletz S, Zillikens D, Schmidt E (2017) Structural proteins of the dermal-epidermal junction targeted by autoantibodies in pemphigoid diseases. Exp Dermatol 26:1154\u20131162. \n                    https:\/\/doi.org\/10.1111\/exd.13446","journal-title":"Exp Dermatol"},{"key":"4291_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00603","author":"RJ Ludwig","year":"2017","unstructured":"Ludwig RJ, Vanhoorelbeke K, Leypoldt F et al (2017) Mechanisms of autoantibody-induced pathology. Front Immunol 8. \n                    https:\/\/doi.org\/10.3389\/fimmu.2017.00603","journal-title":"Front Immunol"},{"key":"4291_CR5","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.jid.2018.01.027","volume":"138","author":"O Varpuluoma","year":"2018","unstructured":"Varpuluoma O, F\u00f6rsti A\u2011K, Jokelainen J et al (2018) Vildagliptin significantly increases the risk of bullous pemphigoid: a Finnish nationwide registry study. J\u00a0Invest Dermatol 138:1659\u20131661. \n                    https:\/\/doi.org\/10.1016\/j.jid.2018.01.027","journal-title":"J Invest Dermatol"},{"key":"4291_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.07.008","author":"J Siegel","year":"2018","unstructured":"Siegel J, Totonchy M, Damsky W et al (2018) Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: a retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy. J\u00a0Am Acad Dermatol. \n                    https:\/\/doi.org\/10.1016\/j.jaad.2018.07.008","journal-title":"J Am Acad Dermatol"},{"key":"4291_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00220","author":"K Kridin","year":"2018","unstructured":"Kridin K, Ludwig RJ (2018) The growing incidence of bullous pemphigoid: overview and potential explanations. Front Med 5. \n                    https:\/\/doi.org\/10.3389\/fmed.2018.00220","journal-title":"Front Med"},{"key":"4291_CR8","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/exd.13401","volume":"26","author":"A-K F\u00f6rsti","year":"2017","unstructured":"F\u00f6rsti A\u2011K, Huilaja L, Schmidt E, Tasanen K (2017) Neurological and psychiatric associations in bullous pemphigoid-more than skin deep? Exp Dermatol 26:1228\u20131234. \n                    https:\/\/doi.org\/10.1111\/exd.13401","journal-title":"Exp Dermatol"},{"key":"4291_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00238","author":"R Bech","year":"2018","unstructured":"Bech R, Kibsgaard L, Vestergaard C (2018) Comorbidities and treatment strategies in bullous pemphigoid: an appraisal of the existing literature. Front Med 5. \n                    https:\/\/doi.org\/10.3389\/fmed.2018.00238","journal-title":"Front Med"},{"key":"4291_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00105-017-4089-y","volume":"69","author":"MM Holtsche","year":"2018","unstructured":"Holtsche MM, Zillikens D, Schmidt E (2018) Mucous membrane pemphigoid. Hautarzt 69:67\u201383. \n                    https:\/\/doi.org\/10.1007\/s00105-017-4089-y","journal-title":"Hautarzt"},{"key":"4291_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.iac.2012.04.002","volume":"32","author":"E Schmidt","year":"2012","unstructured":"Schmidt E, della Torre R, Borradori L (2012) Clinical features and practical diagnosis of bullous pemphigoid. Immunol Allergy Clin North Am 32:217\u2013232. \n                    https:\/\/doi.org\/10.1016\/j.iac.2012.04.002","journal-title":"Immunol Allergy Clin North Am"},{"key":"4291_CR12","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00105-013-2599-9","volume":"64","author":"F Schulze","year":"2013","unstructured":"Schulze F, Kasperkiewicz M, Zillikens D, Schmidt E (2013) Bullous pemphigoid. Hautarzt 64:931\u2013943. \n                    https:\/\/doi.org\/10.1007\/s00105-013-2599-9\n                    \n                   (quiz 944\u2013945)","journal-title":"Hautarzt"},{"key":"4291_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3238\/arztebl.2011.0405","volume":"108","author":"E Schmidt","year":"2011","unstructured":"Schmidt E, Zillikens D (2011) The diagnosis and treatment of autoimmune blistering skin diseases. Dtsch Arztebl Int 108:399\u2013405. \n                    https:\/\/doi.org\/10.3238\/arztebl.2011.0405","journal-title":"Dtsch. Arztebl. Int."},{"key":"4291_CR14","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/ddg.13637_g","volume":"16","author":"N Beek van","year":"2018","unstructured":"van Beek N, Zillikens D, Schmidt E (2018) Diagnostik blasenbildender Autoimmundermatosen. J\u00a0Dtsch Dermatol Ges 16:1077\u20131092. \n                    https:\/\/doi.org\/10.1111\/ddg.13637_g","journal-title":"J Dtsch Dermatol Ges"},{"key":"4291_CR15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/ddg.40_12612","volume":"13","author":"E Schmidt","year":"2015","unstructured":"Schmidt E, Goebeler M, Hertl M et al (2015) S2k-Leitlinie zur Diagnostik des Pemphigus vulgaris\/foliaceus und des bull\u00f6sen Pemphigoids: Diagnostik Pemphigus und bull\u00f6ses Pemphigoid. J\u00a0Dtsch Dermatol Ges 13:713\u2013727. \n                    https:\/\/doi.org\/10.1111\/ddg.40_12612","journal-title":"J Dtsch Dermatol Ges"},{"key":"4291_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1365-2133.2004.06006.x","volume":"151","author":"RM Vodegel","year":"2004","unstructured":"Vodegel RM, Jonkman M, Pas HH, De Jong MCJM (2004) U\u2011serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases. Br J Dermatol 151:112\u2013118. \n                    https:\/\/doi.org\/10.1111\/j.1365-2133.2004.06006.x","journal-title":"Br J Dermatol"},{"issue":"4","key":"4291_CR17","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jaad.2017.11.029","volume":"78","author":"JM Meijer","year":"2018","unstructured":"Meijer JM, Atefi I, Diercks GFH et\u00a0al (2018) Serration pattern analysis for differentiating epidermolysis bullosa acquisita from other pemphigoid diseases. J\u00a0Am Acad Dermatol 78(4):754\u2013759.e6. \n                    https:\/\/doi.org\/10.1016\/j.jaad.2017.11.029","journal-title":"J Am Acad Dermatol"},{"key":"4291_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1750-1172-7-49","volume":"7","author":"N Beek van","year":"2012","unstructured":"van Beek N, Rentzsch K, Probst C et al (2012) Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy. Orphanet J Rare Dis 7:49. \n                    https:\/\/doi.org\/10.1186\/1750-1172-7-49","journal-title":"Orphanet J Rare Dis"},{"key":"4291_CR19","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/bjd.15649","volume":"177","author":"M Sticherling","year":"2017","unstructured":"Sticherling M, Franke A, Aberer E et\u00a0al (2017) An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone. Br J Dermatol 177:1299\u20131305. \n                    https:\/\/doi.org\/10.1111\/bjd.15649","journal-title":"Br J Dermatol"},{"key":"4291_CR20","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/S0140-6736(17)30560-3","volume":"389","author":"HC Williams","year":"2017","unstructured":"Williams HC, Wojnarowska F, Kirtschig G et al (2017) Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a\u00a0pragmatic, non-inferiority, randomised controlled trial. Lancet 389:1630\u20131638. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(17)30560-3","journal-title":"Lancet"},{"key":"4291_CR21","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/ddg.13642","volume":"16","author":"F H\u00fcbner","year":"2018","unstructured":"H\u00fcbner F, Kasperkiewicz M, Knuth-Rehr D et al (2018) Adjuvant treatment of severe\/refractory bullous pemphigoid with protein A immunoadsorption. J\u00a0Dtsch Dermatol Ges 16:1109\u20131118. \n                    https:\/\/doi.org\/10.1111\/ddg.13642","journal-title":"J Dtsch Dermatol Ges"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-018-4291-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-018-4291-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-018-4291-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:34:31Z","timestamp":1572309271000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-018-4291-6"}},"subtitle":["Vorbereitung auf die Facharztpr\u00fcfung: Folge\u00a025"],"short-title":[],"issued":{"date-parts":[[2018,10,29]]},"references-count":21,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["4291"],"URL":"https:\/\/doi.org\/10.1007\/s00105-018-4291-6","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,29]]},"assertion":[{"value":"29 October 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Witte, E.\u00a0Schmidt und R.\u00a0Ludwig geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"The supplement containing this article is not sponsored by industry.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}